INTERFERON-Α

作品数:73被引量:302H指数:10
导出分析报告
相关领域:医药卫生更多>>
相关作者:卢桥生邢同京侯金林骆抗先冯筱榕更多>>
相关机构:中国人民解放军第一军医大学内蒙古医学院附属医院华中科技大学中南大学更多>>
相关期刊:《世界最新医学信息文摘》《Frontiers of Medicine》《Frontiers of Chemical Science and Engineering》《Journal of Wuhan University of Technology(Materials Science)》更多>>
相关基金:国家自然科学基金吉林省卫生厅科研基金国家教育部博士点基金国家高技术研究发展计划更多>>
-

检索结果分析

结果分析中...
选择条件:
  • 期刊=Frontiers of Medicinex
条 记 录,以下是1-2
视图:
排序:
Minimal residual disease-directed immunotherapy for high-risk myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation被引量:3
《Frontiers of Medicine》2019年第3期354-364,共11页Xiaodong Mo Xiaohui Zhang Lanping Xu Yu Wang Chenhua Yan Huan Chen Yuhong Chen Wei Han Fengrong Wang Jingzhi Wang Kaiyan Liu Xiaojun Huang 
Capital's Funds for Health Improvement and Research (No.2018-4-4089);the Key Program of the National Natural Science Foundation of China (No.81530046);Foundation for Innovative Research Groups of the National Natural Science Foundation of China (No.81621001);the Science and Technology Project of Guangdong Province of China (No.2016B030230003);the National Science and Technology Support Program (No.2014BAI09B13);the Project of Health Collaborative Innovation of Guangzhou city (No.201704020214).
The efficacy of minimal residual disease (MRD)-directed immunotherapy,including interferon-α (IFN-α) treatment and chemotherapy plus granulocyte colony-stimulating factor-primed donor leukocyte infusion (chemo-DLI),...
关键词:donor LEUKOCYTE INFUSION HEMATOPOIETIC stem cell transplantation INTERFERON-Α minimal residual disease MYELODYSPLASTIC syndrome 
Interferon-α salvage treatment is effective for patients with acute leukemia/myelodysplastic syndrome with unsatisfactory response to minimal residual disease-directed donor lymphocyte infusion after allogeneic hematopoietic stem cell transplantation被引量:6
《Frontiers of Medicine》2019年第2期238-249,共12页Xiaodong Mo Xiaohui Zhang Lanping Xu Yu Wang Chenhua Yan Huan Chen Yuhong Chen Wei Han Fengrong Wang Jingzhi Wang Kaiyan Liu Xiaojun Huang 
the National Natural Science Foundation of China (No.81400145);the Beijing Talents Fund (No.2015000021223ZK39);the Key Program of the National Natural Science Foundation of China (No.81530046);Foundation for Innovative Research Groups of the National Natural Science Foundation of China (No.81621001);the Science and Technology Project of Guangdong Province of China (No.2016B030230003).
The efficacy of salvage interferon-α(IFN-α) treatment was investigated in patients with unsatisfactory response to minimal residual disease (MRD)-directed donor lymphocyte infusion (DLI)(n=24). Patients who did not ...
关键词:INTERFERON-Α HEMATOPOIETIC stem cell TRANSPLANTATION minimal residual disease DONOR LYMPHOCYTE INFUSION 
检索报告 对象比较 聚类工具 使用帮助 返回顶部